Terry Turner, Drugwatch The number of people taking the gout medication allopurinol has been rising as gout becomes more prevalent. Prescriptions also got a boost after the U.S. Food and Drug Administration limited the use of Uloric (febuxostat) in 2019, effectively leaving allopurinol as the primary first-line medication option for gout patients. But at the […]
Forbes, Kori Hale Facing almost 20,000 lawsuits by women who blame Johnson & Johnson’s talcum powder for causing cancer finally has a $100 million settlement from the manufacturer. The company agreed to settle 1,000 of these cases in bulk. Despite growing concerns of carcinogenic agents, the products giant continued to market and sell its baby […]
Johnson & Johnson has agreed to pay more than US$100 million to resolve over 1,000 lawsuits blaming its baby powder for causing cancer, in the first set of major settlements in four years of litigation, people with knowledge of the pacts said. The accords, struck with several law firms, signal that the world’s largest maker […]
It is necessary to continue urate-lowering therapy in the inpatient setting to decrease the risk of gout flare in hospitalized patients. Gout flare is almost 14-times more likely to develop in hospitalized patients who have allopurinol discontinued upon admission compared to those who have the treatment continued, according to new study findings. The findings, presented […]
September 16, 2020 Press Release DeLauro in a letter to CEO Gorsky: “By concealing any notion of potential asbestos contamination of its baby powder, Johnson & Johnson violated that trust and placed millions of lives at risk.” As a survivor, DeLauro marks Ovarian Cancer Awareness Month with a call on Johnson & Johnson to remove […]
New study shows about a quarter of patients with significant exposure to the drug show signs of retinal damage. A drug widely prescribed for a bladder condition for decades, now appears to be toxic to the retina, the light sensing tissue at the back of the eye that allows us to see. After an initial […]
By Roni Cary Rabin, New York Times An appellate court in Missouri upheld more than $2 billion in damages against Johnson & Johnson, saying the company knew there was asbestos in its baby powder. A Missouri appeals court on Tuesday ordered Johnson & Johnson and a subsidiary to pay $2.1 billion in damages to women […]
The company has faced thousands of lawsuits from cancer patients who claim that its talc was contaminated with asbestos, a known carcinogen, and that the company knew of the risks. Johnson & Johnson is discontinuing North American sales of baby powder made with talc, a product at the center of nearly 20,000 lawsuits filed by […]
A New Jersey federal judge on Monday largely rejected Johnson & Johnson’s efforts to bar plaintiffs’ experts from testifying that J&J’s baby powder contains asbestos and that talc can cause ovarian cancer, opening a path to trials in the multidistrict litigation that contains thousands of cases. In a three-page order and accompanying 141-page opinion, U.S. District […]
Johnson & Johnson‘s attempt to dismantle a $4.69 billion talc verdict met with mixed signals Friday, as a Missouri appellate panel appeared to discount J&J’s complaints that 22 women’s claims were combined into one trial and focused more on the fact that there were 17 out-of-state plaintiffs. The appeal came in a case brought by […]